CSL to lift the hood on its big Vifor acquisition on Monday

CSL investors have been waiting to hear about the blood product giant’s strategy for Vifor after a $US12bn acquisition.

Related Keywords

Australia ,United States ,Australian ,America ,American ,Vifor Pharma ,Rhett Whyman ,Vifor Ferinject ,Andrew Paine ,Jefferie David Stanton ,Abrdn Michelle Lopez ,Fresenius ,European Commission ,Drug Administration ,Michelle Lopez ,Australian Financial Review ,Shane Storey ,David Stanton ,